BIOMARIN PHARMACEUTICAL
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazymeรยฎ (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazymeรยฎ (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvanรยฎ (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.
BIOMARIN PHARMACEUTICAL
Industry:
Biotechnology Developer Platform
Founded:
1997-03-01
Address:
San Rafael, California, United States
Country:
United States
Website Url:
http://www.biomarin.com
Total Employee:
1001+
Status:
Active
Contact:
415-506-6700
Email Addresses:
[email protected]
Total Funding:
585.8 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Amazon IPv6 JsDelivr Microsoft Azure DNS
Current Advisors List
William Young Member of the Board of Directors @ BioMarin Pharmaceutical Board_member
Kenneth M. Bate Board of Directors @ BioMarin Pharmaceutical Board_member
David Pyott Member of the Board of Directors @ BioMarin Pharmaceutical Board_member
Current Employees Featured
Chieze Ibeneche-Nnewihe
Chieze Ibeneche-Nnewihe Director, Business Development and Corporate Strategy @ BioMarin Pharmaceutical Director, Business Development and Corporate Strategy 2020-08-01
Geoff Nichol
Geoff Nichol CMO & SVP, Global Clinical Development @ BioMarin Pharmaceutical CMO & SVP, Global Clinical Development 2016-11-01
Chris Houlder
Chris Houlder Head of Global Cybersecurity @ BioMarin Pharmaceutical Head of Global Cybersecurity 2020-09-01
Kevin Eggan
Kevin Eggan Head of Research and Early Development @ BioMarin Pharmaceutical Head of Research and Early Development 2020-10-01
Victoria Sluzky
Victoria Sluzky Senior VP, Global Quality and Development @ BioMarin Pharmaceutical Senior VP, Global Quality and Development 2003-02-01
Diane White
Diane White Exec. Director, Head of Global Project Management @ BioMarin Pharmaceutical Exec. Director, Head of Global Project Management 2019-10-01
Jean-Jacques Bienaime
Jean-Jacques Bienaime Chairman of the Board & Chief Executive Officer @ BioMarin Pharmaceutical Chairman of the Board & Chief Executive Officer 2005-05-01
Brinda Balakrishnan
Brinda Balakrishnan Group Vice President, Corporate and Business Development @ BioMarin Pharmaceutical Group Vice President, Corporate and Business Development 2015-01-01
Nicole Zilveti
Nicole Zilveti Development Sciences Operations Sr. Admin @ BioMarin Pharmaceutical Development Sciences Operations Sr. Admin 2016-06-01
Paul Stanley
Paul Stanley Senior Director of Facilities @ BioMarin Pharmaceutical Senior Director of Facilities 2013-10-01
Founder
Christopher Starr
Grant Denison
Stock Details
Company's stock symbol is NASDAQ:BMRN
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-11-24 | Prosensa | Prosensa acquired by BioMarin Pharmaceutical | 840 M USD |
2013-01-07 | Zacharon Pharmaceuticals | Zacharon Pharmaceuticals acquired by BioMarin Pharmaceutical | N/A |
2010-08-17 | Zystor | Zystor acquired by BioMarin Pharmaceutical | 115 M USD |
2010-02-10 | LEAD Therapeutics | LEAD Therapeutics acquired by BioMarin Pharmaceutical | 97 M USD |
2009-10-26 | Huxley Pharmaceuticals | Huxley Pharmaceuticals acquired by BioMarin Pharmaceutical | N/A |
2002-02-07 | Glyko Biomedical | Glyko Biomedical acquired by BioMarin Pharmaceutical | N/A |
Newest Events participated
Participated in 14th Annual International Pediatric Orthopaedic Symposium
on 2017-11-28 as sponsor
Participated in Abilities Expo Houston 2015
on 2015-07-31 as exhibitor
Key Employee Changes
Date | New article |
---|---|
2021-10-04 | BioMarin snags Vertex VP as CMO a month after clinical snafu in gene therapy trial |
Official Site Inspections
http://www.biomarin.com Semrush global rank: 1.68 M Semrush visits lastest month: 14.5 K
- Host name: qwvn-d5gc.accessdomain.com
- IP address: 70.32.66.68
- Location: Culver City United States
- Latitude: 34.0141
- Longitude: -118.3983
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90232
Loading ...